Table 1.
Demographic and clinical characteristics of the study cohort.
| Characteristic | HIV-negative (n = 34) |
HIV-positive (n = 43) |
|
|---|---|---|---|
| Years of infectionα | 0 | 14 (9.5–21.0) | |
| ART use duration (months)α | 0 | 29.1 (11.7–75.1) | |
| Age (years)α | 53.5 (48.2–56.7) | 48.1 (43.4–51.0) | |
| Gender (% male) | 64.7 | 69.7 | |
| Race (%) | White | 35 | 39.5 |
| Non-white | 65 | 60.5 | |
| CD4 count (cells/µl)α | — | 342 (195–461.5) | |
| Nadir CD4 (cells/µl)α | — | 83.5 (28.7–288.5) | |
| CD8 count (cells/µl)α | — | 836.5 (719–1357) | |
| CD4/CD8 ratioα | — | 0.25 (0.12–0.46) | |
| Plasma viral load (HIV RNA copies/ml)α | — | 404 (40–926.5) | |
| Viral load <400 HIV RNA copies/mlγ (%) | — | 53.5 | |
| HCV seropositive (%) | — | 42 | |
| Cocaine use (%)β | — | 49 | |
| Alcohol use (%)β | — | 40 | |
| Smoking (%) | 79 | 70 | |
αMedian (Interquartile range).
βBased on patient report.
γViral load below limit of detection.
ART = Antiretroviral therapy, HCV = hepatitis C virus, –Not available.